PROVIDER PROFILE · NPI 1720419864

Amber TranMSN,CRNP, RN, FNP-BC

Nurse PractitionerPhiladelphia, PAI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

429

Unique beneficiaries

—

Total services

627

Distinct HCPCS

Medicare payment

$27K

Peer benchmark

Total Medicare services vs. 7,939 Nurse Practitioner providers in PA — top quintile (cohort median 235).

PRESCRIBING · PART D · 2024

Total Rx claims

615

Beneficiaries

—

Total drug cost

$235K

Distinct drugs

Brand share

5.2%

Top prescribed drugs

Clobetasol Propionate128 claims

Ketoconazole114 claims

Triamcinolone Acetonide70 claims

Hydrocortisone62 claims

Tacrolimus41 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$161

Payment records

By payment type

Food and Beverage$161

REFERRAL NETWORK

Where Amber Tran's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 6 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
THOMAS JEFFERSON UNIVERSITY HOSPITALS INC	121	241
Jason Lee Dermatology · Philadelphia, PA	91	145
Quest Diagnostics Clinical Laboratories Inc Clinical Laboratory · Norristown, PA	38	53
Laboratory Corporation Of America Holdings Clinical Laboratory · Raritan, NJ	21	34
Matthew Keller Dermatology · Philadelphia, PA	14	19
THE PENNSYLVANIA HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA HEALTH SYS	12	35

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history